Attached files

file filename
EX-32.1 - CERTIFICATION - NanoFlex Power Corpf10q0318ex32-1_nanoflex.htm
EX-31.2 - CERTIFICATION - NanoFlex Power Corpf10q0318ex31-2_nanoflex.htm
EX-31.1 - CERTIFICATION - NanoFlex Power Corpf10q0318ex31-1_nanoflex.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

 

For the quarterly period ended March 31, 2018

 

or

 

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

 

For the transition period from __________________ to __________________

 

Commission File Number 333-187308

 

NANOFLEX POWER CORPORATION

(Exact name of registrant as specified in its charter)

 

Florida   46-1904002
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
     
17207 N Perimeter Dr., Suite 210    
Scottsdale, AZ   85255
(Address of principal executive offices)   (Zip Code)

 

480-585-4200

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
(Do not check if smaller reporting company) Emerging growth company
 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 69,421,778 shares of common stock are issued and outstanding as of May 8, 2018.

 

 

  

 

 

 

 

TABLE OF CONTENTS

 

  Page
   
PART I. FINANCIAL INFORMATION  
     
ITEM 1. FINANCIAL STATEMENTS 1
     
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 14
     
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 18
     
ITEM 4. CONTROLS AND PROCEDURES 18
     
PART II. OTHER INFORMATION  
     
ITEM 1 LEGAL PROCEEDINGS 19
     
ITEM 1A. RISK FACTORS 19
     
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 19
     
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 20
     
ITEM 4. MINE SAFETY DISCLOSURES 20
     
ITEM 5. OTHER INFORMATION 20
     
ITEM 6. EXHIBITS 20
     
SIGNATURES 21

 

 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

CONTENTS

 

FINANCIAL STATEMENTS   Page
     
CONSOLIDATED BALANCE SHEETS (Unaudited)   2
     
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)   3
     
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)   4
     
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)   5

 

 1 

 

 

NANOFLEX POWER CORPORATION

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

   March 31, 2018   December 31, 2017 
ASSETS        
         
Current assets:        
Cash  $12,497   $61,459 
Accounts receivable   116,115    40,490 
Unbilled accounts receivable   33,876    27,803 
Prepaid expenses and other current assets   16,128    17,448 
Total current assets   178,616    147,200 
           
Property and equipment, net   10,474    11,843 
           
Total assets  $189,090   $159,043 
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
           
Current liabilities:          
Accounts payable  $1,765,507   $2,093,693 
Accounts payable- related party   15,250    12,372 
Accrued expenses   1,936,776    1,352,078 
Short-term debt, net of unamortized discounts   1,949,166    1,719,690 
Short-term debt - related party   2,496,478    2,496,478 
Convertible debt, net of unamortized discounts and deferred financing costs   2,480,053    2,069,208 
Advances - related party   270,035    343,680 
Total current liabilities   10,913,265    10,087,199 
Long term convertible debt - related party, net of unamortized discounts   199,415    - 
Total liabilities   11,112,680    10,087,199 
           
Stockholders' deficit:          
Common stock, 500,000,000 authorized, $0.0001 par value, 69,421,778 and 67,289,475 issued and outstanding as of March 31, 2018 and December 31, 2017, respectively   6,942    6,729 
Common stock payable   -    681,625 
Additional paid-in capital   208,992,103    205,928,610 
Accumulated deficit   (219,922,635)   (216,545,120)
Total stockholders' deficit   (10,923,590)   (9,928,156)
           
Total liabilities and stockholders' deficit  $189,090   $159,043 

 

See accompanying notes to unaudited consolidated financial statements.

 

 2 

 

 

NANOFLEX POWER CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three Months Ended
March 31,
 
   2018   2017 
         
Revenue  $149,991   $1,700 
Cost of services   (149,991)   (38,002)
Gross loss   -    (36,302)
Operating expenses:          
Research and development  $145,781   $189,161 
Patent application and prosecution fees   327,157    363,603 
Selling, general and administrative expenses   474,944    650,781 
Total operating expenses   947,882    1,203,545 
           
Loss from operations   (947,882)   (1,239,847)
           
Other income (expense):          
Gain on change in fair value of derivative   -    4,481,736 
Loss on extinguishment of debt   (1,820,764)   - 
Gain (loss) on settlement of accrued interest   32,800    (33,600)
Interest expense   (641,669)   (629,513)
Total other income (expense)   (2,429,633)   3,818,623 
           
Net income (loss)  $(3,377,515)  $2,578,776 
           
Net income (loss) per common share:          
Basic  $(0.05)  $0.04 
Diluted  $(0.05)  $(0.02)
           
Weighted average common shares outstanding:          
Basic   68,158,463    60,685,049 
Diluted   68,158,463    76,202,016 

 

See accompanying notes to unaudited consolidated financial statements.

 

 3 

 

 

NANOFLEX POWER CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Three Months Ended
March 31,
 
   2018   2017 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net income (loss)  $(3,377,515)  $2,578,776 
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Depreciation expense   1,369    1,556 
Warrants and options issued as compensation   81,772    192,806 
Interest expense of warrants related to conversion of debt   -    72,591 
Amortization of debt discounts   337,333    465,768 
Loss on extinguishment of debt   1,802,412    - 
(Gain) loss on settlement of accrued interest with stock   (32,800)   33,600 
Common shares issued for services   10,000    - 
Gain on change in fair value of derivative liabilities   -    (4,481,736)
Changes in operating assets and liabilities:          
Prepaid expenses and other current assets   1,320    3,320 
Accounts receivable   (81,698)   - 
Accounts payable   (328,186)   (231,166)
Accounts payable - related party   2,878    (2,470)
Accrued expenses   680,698    131,608 
Net cash used in operating activities   (902,417)   (1,235,347)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchases of fixed assets   -    (2,437)
Net cash used in investing activities   -    (2,437)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from sale of common shares and warrants   -    50,000 
Subscription proceeds received for common stock and warrants to be issued   -    193,750 
Borrowings on related party debt   300,000    500,000 
Borrowings on promissory note debt   75,000    - 
Borrowings on convertible debt   595,100    650,000 
Repayments on convertible debt   (43,000)   - 
Advances received from related party   8,000    10,000 
Advances repaid to related party   (81,645)   (40,000)
Net cash provided by financing activities   853,455    1,363,750 
           
NET INCREASE (DECREASE) IN CASH   (48,962)   125,966 
Cash, beginning of the period   61,459    2,986 
Cash, end of the period  $12,497   $128,952 
           
SUPPLEMENTAL CASH FLOW INFORMATION          
Cash paid for interest  $-   $9,670 
Cash paid for income taxes  $-   $- 
           
NON-CASH INVESTING AND FINANCING ACTIVITIES          
Principal and interest converted into common stock   -    388,300 
Common shares issued for legal settlement   681,625    - 
Common stock and warrants issued for accrued interest   23,200    168,000 
Debt discount on beneficial conversion feature and warrants issued with convertible debt   

494,697

    537,891 
Accrued interest roll over to principal per modification   40,000    - 

 

See accompanying notes to unaudited consolidated financial statements.

 

 4 

 

 

NANOFLEX POWER CORPORATION

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

1. BACKGROUND, BASIS OF PRESENTATION, AND GOING CONCERN

 

Background

 

NanoFlex Power Corporation (‘we” “our”, the “Company”), formerly known as Universal Technology Systems, Corp., was incorporated in the State of Florida on January 28, 2013. On September 24, 2013, the Company completed the acquisition of Global Photonic Energy Corporation, a Pennsylvania corporation (“GPEC”), pursuant to a Share Exchange Agreement (the “Share Exchange Transaction”). Immediately following the closing of the Share Exchange Transaction, the Company owned 100% of the equity interests of GPEC and GPEC became a wholly-owned subsidiary of the Company. On November 25, 2013, the Company changed its name from “Universal Technology Systems, Corp.” to “NanoFlex Power Corporation” and its trading symbol was changed to “OPVS” on December 26, 2013.

 

GPEC was incorporated in Pennsylvania on February 7, 1994. The Company is organized to fund, develop, commercialize and license advanced photovoltaic technologies that enable thin film solar products with what we believe to be industry-leading efficiencies, light weight, flexibility, and low total system cost.

 

These technologies are targeted at certain broad applications, including: (a) portable and off-grid power generation, (b) building applied photovoltaics (“BAPV”), (c) building integrated photovoltaics (“BIPV”), (d) space vehicles and unmanned aerial vehicles (“UAVs”), (e) semi-transparent solar power generating windows or glazing, and (f) ultra-thin solar films for automobiles or other consumer applications.

 

We believe these technologies have been demonstrated in a laboratory environment with our research partners. The Company is currently taking steps to pursue product development and commercialization on some of these technologies in collaboration with industry partners and potential customers.

 

Basis of Presentation

 

The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures have been omitted pursuant to such rules and regulations. In the opinion of management, the accompanying consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the interim periods presented. These consolidated financial statements should be read in conjunction with our audited consolidated financial statements and notes thereto for the fiscal year ended December 31, 2017 included in our Annual Report on Form 10-K. The results of operations for the three months ended March 31, 2018 are not necessarily indicative of results to be expected for the full fiscal year or any other periods.

 

The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make a number of estimates and judgments that affect the reported amounts of assets, liabilities, expenses, and related disclosures. Actual results may differ from these estimates.

 

Certain balances were reclassified from Convertible debt, net of unamortized discounts and deferred financing costs to short-term debt, net of unamortized discounts, net for the year ended December 31, 2017 to conform to the current year presentation.

 

Revenue Recognition

 

Adoption of ASC Topic 606, "Revenue from Contracts with Customers"

 

On January 1, 2018, we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Topic 605.

 

There was no impact to the opening balance of accumulated deficit or revenues for the quarter ended March 31, 2018 as a result of applying Topic 606.

 

The Company applies a five-step approach in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer, (2) identifying the performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations in the contract and (5) recognizing revenue when the performance obligation is satisfied. Substantially all of the Company’s revenue is recognized at the time control of the products transfers to the customer.

 

 5 

 

 

The Company generates revenue from our Joint Development Agreements (“JDA’s”) and our ARL contract. R&D engineering services through JDA’s are a core component of the Company’s operations and business model, since they are a necessary prerequisite to obtaining intellectual property licensing agreements with customers. As such, R&D engineering services are expected to be a sustained revenue stream for the Company as it works with additional customers and the services constitute a portion of the Company’s ongoing central operations. The Company has identified the promise to provide engineering services as its performance obligation, which is satisfied over time. The Company has a right to consideration from its customer an amount that corresponds directly with the value to the customer of the Company’s performance completed to date. As allowed by a practical expedient in Topic 606, the entity recognizes revenue in the amount to which the entity has a right to invoice. The term between invoicing and when payment is due is not significant.

 

Due to the fact that the client only has one type of service and only a few customers, disaggregation is deemed unnecessary.

 

Going Concern

 

The Company has generated limited revenue to date. The Company has a working capital deficit of $10,734,649 and an accumulated deficit of $219,922,635 as of March 31, 2018. The ability of the Company to continue as a going concern is dependent on raising capital to fund ongoing operations and carry out its business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence. To date, the Company has funded its initial operations primarily by way of the sale of equity securities, convertible note financing, short term financing from private parties, and advances from related parties.

  

Fair Value

 

ASC 820 Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

 

Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

 

Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services.

 

Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort.

 

The following table sets forth a reconciliation of changes in the fair value of financial assets and liabilities classified as Level 3 in the fair value hierarchy:

 

   Significant Unobservable 
   Inputs 
   (Level 3) 
   Three Months Ended
March 31,
 
   2018   2017 
Beginning balance  $-   $11,985,141 
Change in fair value        (4,481,736)
Ending balance  $-   $7,503,405 

 

 6 

 

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU No. 2016-02,” Leases” (Topic 842) which includes a lessee accounting model that recognizes two types of leases - finance leases and operating leases. The standard requires that a lessee recognize on the balance sheet assets and liabilities for leases with lease terms of more than 12 months. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will depend on its classification as a finance or an operating lease. New disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases are also required. These disclosures include qualitative and quantitative requirements, providing information about the amounts recorded in the financial statements. ASU 2016-02 will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the effect its adoption of this standard, if any, on our consolidated financial position, results of operations or cash flows.

 

In May 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients”, to clarify certain core recognition principles including collectability, sales tax presentation, noncash consideration, contract modifications and completed contracts at transition and disclosures no longer required if the full retrospective transition method is adopted. The effective date and transition requirements for these amendments are annual reporting periods beginning after December 15, 2017, including interim reporting periods therein, and that would also permit public entities to elect to adopt the amendments as of the original effective date as applicable to reporting periods beginning after December 15, 2016. The new guidance allows for the amendment to be applied either retrospectively to each prior reporting period presented or retrospectively as a cumulative-effect adjustment as of the date of adoption.  We have identified changes to our business processes and internal controls relating to contracts and disclosures that are needed upon the adoption of the new guidance. We adopted the new guidance on January 1, 2018, using the modified retrospective method applied to those contracts which were not completed as of that date. See revenue recognition policy above for further details.

 

In May 2017, the FASB issued ASU No. 2017-09, “Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting”, to provide clarity and reduce both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, Compensation—Stock Compensation, to a change to the terms or conditions of a share-based payment award. The ASU provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in ASC 718. The amendments are effective for fiscal years beginning after December 15, 2017 and should be applied prospectively to an award modified on or after the adoption date. Early adoption is permitted, including adoption in an interim period. The Company adopted the standard on January 1, 2018 and this amendment did not have a material impact on its consolidated financial statements.

 

2. DEBT

 

Short Term Convertible Debt

 

During the three months ended March 31, 2018, the Company borrowed an aggregate of $595,100, net of original issue discounts and fees of $53,956, under convertible notes payable. As of March 31, 2018, and December 31, 2017, the Company had outstanding convertible notes payable of $2,480,053 and $2,069,208, net of unamortized discounts of $563,438 and $390,687, respectively. The outstanding convertible notes of the Company are unsecured, bear interest between 0% and 12% per annum and mature between July 2018 and March 2019. Aggregate amortization of the debt discounts on convertible debt for the three months ended March 31, 2018 and 2017 was $211,406 and $406,971, respectively.

 

Three of the above referenced convertible notes payable are convertible at $0.50 per share. One of the above referenced notes is convertible at $0.50 per share except that if an event of default occurs, the conversion price becomes variable. One of the above referenced notes is convertible at $0.50 per share for the first 180 days following its issuance, and thereafter at a conversion price equal to 60% of the lowest sale price of the common stock during the 20 consecutive trading days prior to the date of conversion. One of the above referenced notes is convertible 180 days after issuance at a conversion price equal to 61% of the market price (market price is the average of the lowest two trading prices and trading price is the closing bid price of the common stock on a day the common stock is traded). One of the above referenced notes has an optional conversion into a subsequent note offering at a 15% discount.

 

 7 

 

 

During the three months ended March 31, 2018, the Company paid off short-term convertible debt of $43,000. This resulted in a prepayment penalty loss recorded as loss on debt extinguishment of $18,352.

 

During the three months ended March 31, 2018, an aggregate of $19,056 of original issue discounts were added to two convertible notes as a result of the Most Favored Nations Provision triggered by a transaction with another noteholder. In addition, 158,333 warrants to purchase shares of the Company’s common stock were issued with a 10-year term and an exercise price of $1.00 per share. The Company fair valued the warrants using the black-scholes model and recorded a loss on extinguishment of debt of $33,237.

 

Short Term Convertible Debt - Related Party

 

In October 2017, the Company entered into an agreement with a major shareholder pursuant to which the Company and the major shareholder agreed to convert six previously issued promissory notes issued to the major shareholder upon their specific expiration dates, together with an additional investment amount of $1,000,000, which was received by the Company on October 18, 2017, into a convertible promissory note which totaled $2,496,478. This note has a term of one year and accrues interest at 10% for every four months that it is issued and can be converted at the option of the major shareholder into an investment into the Company’s next offering of its convertible promissory notes and warrants, at a 15% discount thereto. Further, pursuant to this agreement, on October 18, 2017, the major shareholder was issued a warrant, with a ten-year term, to purchase 1,000,000 shares of the Company’s common stock at an exercise price of $0.50. The relative fair value of the 1,000,000 warrants was $247,586 which was recorded as a loss on extinguishment of debt since the change in value was greater than 10%. This note also gave rise to a beneficial conversion feature of $116,208 which is recognized as additional paid in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the note. The note also contains an additional warrant expense of $1,132,999 associated with the warrants that are to be issued upon conversion, which is to be recognized only upon conversion.

 

As of March 31, 2018, and December 31, 2017, the Company had outstanding short term related party convertible notes payable of $2,496,478.

 

Long Term Convertible Debt - Related Party

 

In March 2018, the Company borrowed $300,000 under a long-term note agreement with a major shareholder. The note accrues interest at 8% per year payable in stock the first two years and in cash or stock thereafter, at the shareholders choice, and has a 5-year term. Further, the major shareholder was issued 140,000 shares of common stock and a warrant to purchase 500,000 shares of the Company’s common stock with a 7-year term and an exercise price of $0.60 per share. This note is convertible at $0.60 per share into common stock. The relative fair value of the 500,000 warrants was $108,300 which was recognized as a discount to the debt. The debt discount is being recognized on a straight-line basis over the term of the note. Amortization expense was $7,715 during the three months ended March 31, 2018.

 

As of March 31, 2018, and December 31, 2017, the Company had outstanding long term related party convertible notes payable of $199,415 and $0, net of unamortized discounts of $100,585 and $0.

 

Short Term Non-Convertible Debt

 

During the three months ended March 31, 2018, the Company borrowed an aggregate of $75,000 under non-convertible notes payable. As of March 31, 2018, and December 31, 2017, the Company had outstanding notes payable of $1,949,166 and $1,719,690, net of unamortized discounts of $90,834 and $175,311. These notes payable of the Company are unsecured, bear interest between 0% and 12% per annum and mature between January 2018 and September 2018. Aggregate amortization of the debt discounts on non-convertible debt for the three months ended March 31, 2018 and 2017 was $118,212 and $58,797, respectively.  Total debt discount recorded in the three months ended March 31, 2018 was $33,736.

 

 8 

 

 

During the three months ended March 31, 2018, the Company entered into letter agreements with three non-convertible noteholders, pursuant to which an aggregate of 5,300,000 warrants and 100,000 shares of the Company’s common stock were issued in exchange for extending the maturity dates of these notes. The warrants have a 10-year term and an exercise price of $0.50 per share. The modification of these non-convertible notes resulted in accrued interest added to principal of $40,000, an additional $30,000, which was recorded as loss on extinguishment of debt.

 

Advances – Related Party

 

During the three months ended March 31, 2018, the Company received advances from its Chief Executive Officer totaling $8,000, and repaid advances totaling $81,645. During the three months ended March 31, 2017, the Company received advances from its Chief Executive Officer totaling $10,000, and repaid advances totaling $40,000.

   

As of March 31, 2018, and December 31, 2017, the aggregate outstanding balance of advances to related parties was $270,035 and $343,680, respectively.

 
Derivative Liabilities - Convertible Notes

  

As of January 1, 2017, The Company changed its method of accounting for the debt and warrants through the early adoption of ASU 2017-11. The Company reclassified the December 31, 2016, conversion option derivative liabilities balance of $3,156,736 to additional paid in capital and accumulated deficit on its January 1, 2017 consolidated balance sheets.

 

Accounts Payable - Related Party

 

As of March 31, 2018, and December 31, 2017, there is $15,250 and $12,372, respectively, due to related parties, which is non-interest bearing and due on demand.

 

3. EQUITY

 

Common Stock

 

On January 15, 2018, the Company issued 30,303 shares of its common stock to a consultant pursuant to a consulting agreement. The fair value of the common stock was determined to be $10,000 based on the stock price on January 15, 2018.

 

On February 12, 2018, the Company entered into a letter agreement with an investor pursuant to which, the investor agreed to extend the maturity date of a promissory note which expired on February 12, 2018, to a new maturity date of May 14, 2018, and in exchange for agreeing to extend the maturity date of such note, the investor was issued 100,000 shares of the Company’s common stock and a warrant to purchase 2,000,000 shares of the Company’s common stock with a $0.50 exercise price per share and a 10 year term. The fair value of the warrants was determined to be $599,096 using the Black-Scholes option pricing model. The fair value of the common stock was determined to be $30,900 based on the stock price on February 12, 2018. These fair values were recorded as a total loss on extinguishment of debt of $629,996.

 

On February 23, 2018, the Company issued 1,750,000 shares of its common stock related to the settlement with John Kuhns. The fair value of the common stock was determined to be $681,625 based on the stock price on August 29, 2017, which was the original grant date.

 

On March 5, 2018, the Company issued 140,000 shares of the Company’s common stock to a related party pursuant to a letter agreement. The relative fair value of the common stock was determined to be $25,040 and is included in the beneficial conversion feature discount discussed in the warrants section below.

 

In March 2018, the Company issued 112,000 shares of the Company’s common stock to certain note holders in exchange for accrued interest of $56,000. The fair value of the common stock was determined to be $23,200 and resulted in a gain on settlement of accrued interest of $32,800.

 

 9 

 

 

Stock Options

  

A summary of stock option activity during the three months ended March 31, 2018 is as follows:

 

     Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Life (years) 
Outstanding at December 31, 2017   215,000   $0.65    9.0 
Granted   -    -      
Exercised   -    -      
Forfeited   -    -      
Outstanding at March 31, 2018   215,000   $0.65    9.8 
Exercisable at March 31, 2018   69,000   $0.66    9.5 

 

Stock option awards are expensed on a straight-line basis over the requisite service period. During the three months ended March 31, 2018 and 2017 the Company recognized expense of $9,811, and $6,720, respectively, associated with stock option awards. At March 31, 2018, future stock compensation expense (net of estimated forfeitures) not yet recognized was $102,852 and will be recognized over a weighted average remaining vesting period of 2.6 years.

 

The intrinsic value of the Company’s stock options outstanding was $0 at March 31, 2018.

 

Warrants

 

Employee Warrants

 

On September 1, 2015, the Company entered into an Employment Agreement (the “Employment Agreement”) with Mark Tobin in his capacity as the Company’s Chief Financial Officer. Pursuant to the Employment Agreement, on September 1, 2015 the Company issued Mr. Tobin warrants to purchase 1,500,000 shares of the Company’s common stock at $1.00 per share (the “Warrant Shares”). The fair value of the warrants was determined to be $2,835,061 using the Black-Scholes option pricing model. 375,000 of the Warrant Shares vested on September 1, 2015, an additional 375,000 warrant shares vested on the first anniversary date of the Employment Agreement. On May 15, 2017, Mr. Tobin terminated his employment with the Company. On May 15, 2017, the Company entered into an agreement with Mr. Tobin allowing his third tranche of 375,000 Warrant Shares to vest on September 1, 2017 in exchange for consulting services. The remaining fourth tranche of 375,000 warrants were forfeited upon termination of the Employment Agreement. The agreement contains an anti-dilution provision and therefore the exercise price was reset to $0.50 per share during the year ended December 31, 2017.Warrant expense of $147,659 was recognized during the three months ended March 31, 2017.

 

On May 18, 2017, the Company entered into an Employment Agreement (the “Employment Agreement”) with Ron DaVella in his capacity as the Company’s Chief Financial Officer. Pursuant to the Employment Agreement, on May 18, 2017 the Company issued Mr. DaVella warrants to purchase 1,800,000 shares of the Company’s common stock at $0.50 per share (the “Warrant Shares”). The fair value of the warrants was determined to be $743,416 using the Black-Scholes option pricing model. 450,000 of the Warrant Shares vested on May 18, 2017, an additional 450,000 warrant shares will vest on the first anniversary date of the Employment Agreement, an additional 450,000 warrant shares will vest on the second anniversary date of the Employment Agreement, and, an additional 450,000 warrant shares will vest on the third anniversary date of the Employment Agreement. Warrant expense of $85,183 and $0 was recognized during the three months ended March 31, 2018 and 2017, respectively.

  

Total warrant expense for employee warrants of non-forfeited tranches was $85,183 and $147,659 for the three months ended March 31, 2018 and 2017, respectively.

 

 10 

 

 

Non-Employee Warrants

 

On November 4, 2015, the Company entered into an amendment to the Independent Contractor Agreement (the “Amendment”) with a service provider pursuant to which the service provider is to be issued warrants to purchase 2,400,000 shares of the Company’s common stock at $1.00 per share (the “Warrant Shares”). 1,200,000 of the Warrant Shares vested on November 4, 2015, an additional 600,000 Warrant Shares vested on November 4, 2016, and an additional 600,000 Warrant Shares vested on November 4, 2017. The fair value of the first 1,200,000 Warrants Shares was determined to be $1,115,964 using the Black-Scholes option pricing model and was recognized as expense during the year ended December 31, 2015. The fair value of the 600,000 Warrant Shares that vested November 4, 2016 was determined to be $559,900 and was recognized as expense during the year ended December 31, 2016. The fair value of the 600,000 Warrants Shares that vested November 4, 2017 was $183,660 and was recognized as expense during the year ended December 31, 2017.  Warrant expense of $68,412 was recaptured during the three months ended March 31, 2017.

 

On May 13, 2016, the Company entered into an agreement with a service provider pursuant to which the service provider is to be issued warrants to purchase 1,000,000 shares of the Company’s common stock at $1.00 per share (the “Warrant Shares”). 500,000 of the Warrant Shares vested on May 13, 2016, 250,000 warrant shares vested on May 13, 2017, and an additional 250,000 Warrant Shares will vest on the second anniversary date of the agreement. The agreement contains an anti-dilution provision and therefore the exercise price was reset to $0.50 per share during the year ended December 31, 2016. The fair value of the first 500,000 Warrant Shares was determined to be $388,888 using the Black-Scholes option pricing model and was recognized as expense and as derivative liabilities during the year ended December 31, 2016. The fair value of the first 250,000 Warrant Shares was determined to be $93,545 using the Black-Scholes option pricing model of which $52,457 of expense was recaptured during the year ended December 31, 2017. The fair value of the remaining tranche of 250,000 Warrant Shares was determined to total $60,392 as of March 31, 2018 using the Black-Scholes option pricing model of which $13,222 of expense was recaptured during the three months ended March 31, 2018.

 

During the three months ended March 31, 2018, the Company issued 250,000 warrants for the Company’s common shares with a strike price of $0.50 per share, with promissory notes of $75,000. The relative fair value of the warrants of $33,736 was recognized as a debt discount which is being amortized on a straight-line basis over the term of the notes. The Company recognized interest expense of $7,203 associated with the amortization of debt discount on the notes and warrants issued during the current year for the three months ended March 31, 2018.

 

During the three months ended March 31, 2018, the Company issued an aggregate of 1,494,000 warrants with six convertible notes totaling $644,056. The relative fair value of the warrants was determined to be $288,919, which was recognized as a discount to the debt. This note also gave rise to a beneficial conversion feature of $63,742 which is recognized as additional paid in capital and a corresponding debt discount. All debt discounts are being recognized on a straight-line basis over the term of the notes. Amortization expense was $67,033 for the three months ended March 31, 2018.

 

During the three months ended March 31, 2018, the Company issued an aggregate of 5,458,333 warrants to purchase the Company’s common stock in conjunction with debt modification agreements. The warrants have a 10-year term and exercise prices ranging from $0.50 to $1.00 per share. The fair value of the warrants was determined to be $1,741,512 using the Black-Scholes option pricing model which was recognized as loss on extinguishment of debt during the three months ended March 31, 2018.

 

The Company recaptured a total of $13,222 on warrants issued to non-employees for services provided during the three months ended March 31, 2018.

 

 11 

 

 

The following summarizes the warrant activity for the three months ended March 31, 2018:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (in years)   Aggregate Intrinsic Value 
                 
Outstanding as of December 31, 2017   79,381,367   $0.51    4.4   $10,700 
Granted   7,757,333    0.53           
Expired   -    -           
Exercised   -    -           
                     
Outstanding as of March 31, 2018   87,138,700   $0.62    4.6   $- 
                     
Exercisable as of March 31, 2018   85,538,700   $0.63    4.6   $- 

 

Derivative Liabilities - Warrants

 

As of January 1, 2017, the Company changed its method of accounting for the debt and warrants through the early adoption of ASU 2017-11. The Company reclassified the December 31, 2016 warrant derivative liabilities balance of $8,828,405 to additional paid in capital and accumulated deficit on its January 1, 2017 consolidated balance sheets. The statements of operations and cash flows for the three months ended March 31, 2017 have not been restated.

 

4. NET EARNINGS (LOSS) PER SHARE

 

   Three Months Ended
March 31,
 
   2018   2017 
         
Net income (loss)  $(3,377,515)  $2,578,776 
Less: decrease in fair value of warrants, net of income tax   -    (2,902,756)
Less: decrease in fair value of convertible debt, net of income tax   -    (1,293,707)
Less: interest expense - convertible debt   -    (47,710)
Loss available to common stockholders   (3,377,515)   (1,665,397)
           
Basic weighted average common shares outstanding   68,158,463    60,685,049 
Plus: incremental shares from assumed exercise- warrants   -    11,016,303 
Plus: incremental shares from assumed conversion- convertible debt   -    4,100,000 
Plus: incremental shares from assumed conversion-units   -    400,663 
Adjusted weighted average common shares outstanding   68,158,463    76,202,015 
           
Net income (loss) per share:          
Basic  $(0.05)  $0.04 
Diluted  $(0.05)  $(0.02)

 

5. COMMITMENTS AND CONTINGENCIES

 

Lease Commitments

 

In November 2013, the Company entered into a 60-month lease agreement for its corporate facility in Arizona. Total rent expense for the three months ended March 31, 2018 and 2017 was $35,158 and $29,194, respectively.

 

 12 

 

 

Future minimum lease payments are as follows:

 

2018 (remainder)  $50,258 
2019   - 
2020   - 
2021   - 
2022   - 
Thereafter   - 
Total  $50,258 

 

Concentrations

 

All of the Company’s revenue and accounts receivable are currently earned from one customer.

 

Legal Matters

 

As reported in the Company’s prior filings, and specifically as described in the Company’s quarterly report for the quarter ended June 30, 2017, which was filed with the SEC on August 9, 2017, the Company was a party to a lawsuit in the United States District Court Southern District of New York, which was brought by John D. Kuhns. The parties have settled the matter. Pursuant to the settlement, all claims against the Company have been dismissed in exchange for issuing Mr. Kuhns 1,750,000 shares of the Company’s common stock and a promissory note for $125,000. This resulted in a loss on settlement of $633,292 recognized during 2017. The note is accruing interest at 12% per annum and due on May 31, 2018. The common stock was issued during the three months ended March 31, 2018.

 

6. SUBSEQUENT EVENTS

 

In April 2018, the Company borrowed an aggregate of $75,000 and issued two non-convertible promissory notes with terms ranging from three to six months and interest rates of 8% per year. In connection with one of the notes, the Company issued warrants to purchase 100,000 shares of the Company’s Common Stock with a $0.50 exercise price per share and a 10-year term.

 

In April and May of 2018, the Company borrowed an aggregate of $310,000 and issued three convertible promissory notes with terms ranging from 9 months to five-years and interest rates ranging from 8% to 12% per year. In connection with these notes, the Company issued warrants to purchase an aggregate of 278,333 shares of the Company’s Common Stock with exercise prices ranging from $0.60 to $1.00 per share and terms ranging from five to seven years.

 

In May 2018, the Company issued warrants to purchase 300,000 shares of the Company’s Common Stock in exchange for services. The warrants have an exercise price of $0.50 and a 10-year term.

 

In May 2018, the Company paid off short-term convertible debt of $108,000. This resulted in a prepayment penalty loss recorded as loss on debt extinguishment of $54,388.

 

 13 

 

 

ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and notes thereto as of and for the year ended December 31, 2017 and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed on March 27, 2018.

 

SPECIAL NOTE OF CAUTION REGARDING FORWARD-LOOKING STATEMENTS

 

CERTAIN STATEMENTS IN THIS REPORT, INCLUDING STATEMENTS IN THE FOLLOWING DISCUSSION, ARE WHAT ARE KNOWN AS “FORWARD-LOOKING STATEMENTS,” WHICH ARE BASICALLY STATEMENTS ABOUT THE FUTURE. FOR THAT REASON, THESE STATEMENTS INVOLVE RISK AND UNCERTAINTY SINCE NO ONE CAN ACCURATELY PREDICT THE FUTURE. WORDS SUCH AS “PLANS,” “INTENDS,” “WILL,” “HOPES,” “SEEKS,” “ANTICIPATES,” “EXPECTS” AND THE LIKE OFTEN IDENTIFY SUCH FORWARD-LOOKING STATEMENTS BUT ARE NOT THE ONLY INDICATION THAT A STATEMENT IS A FORWARD-LOOKING STATEMENT. SUCH FORWARD-LOOKING STATEMENTS INCLUDE STATEMENTS CONCERNING OUR PLANS AND OBJECTIVES WITH RESPECT TO THE PRESENT AND FUTURE OPERATIONS OF THE COMPANY, AND STATEMENTS WHICH EXPRESS OR IMPLY THAT SUCH PRESENT AND FUTURE OPERATIONS WILLOR MAY PRODUCE REVENUES, INCOME OR PROFITS. NUMEROUS FACTORS AND FUTURE EVENTS COULD CAUSE THE COMPANY TO CHANGE SUCH PLANS AND OBJECTIVES OR FAIL TO SUCCESSFULLY IMPLEMENT SUCH PLANS OR ACHIEVE SUCH OBJECTIVES OR CAUSE SUCH PRESENT AND FUTURE OPERATIONS TO FAIL TO PRODUCE REVENUES, INCOME OR PROFITS. THEREFORE, THE READER IS ADVISED THAT THE FOLLOWING DISCUSSION SHOULD BE CONSIDERED IN LIGHT OF THE DISCUSSION OF RISKS AND OTHER FACTORS CONTAINED IN THIS REPORT ON FORM 10-Q AND THE COMPANY’S FORM 10-K FILED ON MARCH 27, 2018. NO STATEMENTS CONTAINED IN THE FOLLOWING DISCUSSION SHOULD BE CONSTRUED AS A GUARANTEE OR ASSURANCE OF FUTURE PERFORMANCE OR FUTURE RESULTS.

 

NanoFlex Power Corporation is engaged in the development, commercialization, and licensing of advanced photovoltaic technologies that enable thin film solar products with industry-leading efficiencies, light weight, flexibility, and low total system cost. NanoFlex has the exclusive worldwide license to the intellectual property resulting from the Company’s sponsored research programs, which have resulted in an extensive portfolio of issued and pending U.S. patents, plus their foreign counterparts. The patents are referred to herein as being the Company’s patents or as our “IP”. Building upon the sponsored research, the Company plans to work with industry partners to commercialize its technologies to target key applications where it believes products incorporating its technologies present compelling competitive advantages.

 

These patented and patent-pending technologies fall into two general categories – (1) cost reducing and performance-enhancing fabrication processes and device architectures for ultra-high efficiency Gallium Arsenide (“GaAs”)-based solar thin films and (2) organic photovoltaic (“OPV”) materials, architectures, and fabrication processes for low cost, ultra-thin solar films offering high quality aesthetics, such as semi-transparency and tinting, and highly flexible form factors. The technologies are targeted at certain broad applications that require high power conversion efficiency, flexibility, and light weight. These applications include: (a) portable and off-grid solar power generation, (b) BAPV, (c) BIPV, (d) space vehicles and UAVs, (e) semi-transparent solar power generating glazing or windows (f) ultra-thin solar films for automobiles or other consumer applications and (g) solar powered sensors. The Company believes these technologies have been demonstrated in a laboratory environment with our research partners.  

 

The Company currently holds exclusive rights to an extensive portfolio of issued and pending U.S. patents, plus their foreign counterparts, which cover architecture, processes and materials for flexible, thin-film organic photovoltaic (“OPV”) and Gallium Arsenide (“GaAs”)-based solar technologies. In addition, we have an extensive collection of patents in process. Some of our technology holdings include foundational concepts in the following areas:

 

  Tandem organic solar cell
  Fullerene acceptors
  Blocking layers
  New materials for visible and infrared sensitivity
  Scalable growth technologies
  Inverted solar cells
  Materials for enhanced light collection via multi-exciton generation
  Mixed layer and nanocrystalline cells
  Solar films, coatings, or paints
  Semi-transparent cells
  Ultra-low cost, ultra-high efficiency, flexible thin film GaAs cells
  Accelerated and recyclable liftoff process
  Cold-weld bonding of GaAs solar cells to plastic substrates and metal foils
  Micro-inverters monolithically integrated into GaAs solar cells
  Low cost, thermo-formed plastic mini-compound parabolic concentrator arrays

 

 14 

 

 

Plan of Operation and Liquidity and Capital Resources

 

Overall Operating Plan

 

Our business model is oriented around licensing and sublicensing processes and technologies to large, well-positioned commercial partners who can provide manufacturing and marketing capabilities to enable rapid commercial growth. These manufacturing partners can supply customers directly, from which we expect to receive license royalties. Additionally, these manufacturing partners can also serve as a source of solar cell supply for NanoFlex to provide products to customers on its own through a “fab-less” manufacturing model. We believe this “fab-less” manufacturing model is necessary during the early stages of developing new markets.

 

We have made contact with major solar cell electronics manufacturers and other major companies world-wide and are finding potential commercial interest in both our high efficiency and OPV technologies. We are seeking to work closely with those companies interested in our technology solutions to develop proof-of-concept prototypes and processes to mitigate commercialization risks and gain early market entry and acceptance.

 

We have identified high efficiency thin film solar technologies as our nearest term market opportunity. A key to reducing the risk to market entry of our high efficiency technologies by our partners is for us to demonstrate our technologies on their product designs and fabrication processes through technology transfer and joint development. To support this joint development, we have established our own engineering team and plan to expand this team contingent on our ability to secure sponsored development funding and/or raise the necessary capital. This team serves several key functions, including working closely with our sponsored research organizations and its industry partners to integrate and customize our proprietary processes and technologies into the partner’s existing product designs and fabrication processes. In addition, the Company is pursuing commercialization efforts in the emerging IoT market with solar powered sensors. In conjunction with facilitating technology transfer, our engineering team will also work closely with downstream partners and customers such as military users for mobile field applications, system integrators, installers, and architects for BAPV and BIPV applications, and engineering, procurement, and construction (“EPC”) companies and project developers for solar farm applications. This customer interaction allows us to better understand application specific requirements and incorporate these requirements into its product development cycle.

 

To support this work, our engineering team leverages the facilities and equipment at the University of Michigan on a recharge basis, which we believe is a cost-effective approach to move the technologies toward commercialization. We believe that this allows our engineering team to work directly with industry partners to acquire early licenses to use our intellectual property without the need for large-scale capital investment in clean room facilities and solar cell fabrication equipment.

 

We are pursuing sponsored development funding to generate revenue in the near-term. In connection with our focus on potential government-sponsored research projects, on June 19, 2017, the Company announced that that it is part of a consortium that was awarded a $5.7 million contract from the Army Research Laboratory’s Army Research Office to develop high power, flexible, and lightweight solar modules for portable power applications. The consortium consists of NanoFlex, SolAero, the University of Michigan, and the University of Wisconsin. Pursuant to the foregoing and as part of the consortium, SolAero was awarded a 4-year contract amounting to $5.7 million with the Army Research Lab (ARL) to develop solar power mats.  SolAero has engaged the Company as a subcontractor for $3.3 million over 4 years of which $1.6 million will be provided to the University of Michigan as a subcontractor to the Company. The Company’s contract with SolAero provides for direct reimbursement of the Company’s costs, including indirect overheard. Having an established technical team enables us to more effectively pursue and execute sponsored research projects from the Department of Defense (“DoD”), the Department of Energy (“DOE”), and the National Aeronautics and Space Administration (“NASA”), each of which has interests in businesses that can deliver ultra-lightweight, high-efficiency solar technologies for demanding applications. However, there can be no assurance that the Company can effectively pursue such research projects, nor if it can, that such pursuit will be successful.  

 

Another potential revenue source is from JDAs and license agreements with existing solar cell manufacturers, similar to the JDA with SolAero. Once we are able to initially demonstrate the efficacy of our processes and technologies on partners’ products and fabrication processes, we expect to be in a position where we can sign licenses covering further joint development, IP licensing, solar cell supply, and joint marketing, as applicable. We anticipate that partnerships with one or more of the existing high efficiency solar cell manufacturers can be supported by our engineering team, and result in near-term revenue opportunities, as we have demonstrated with our current joint development partner.

 

 15 

 

 

As reported in the Company’s Form 8-K filed with the SEC on February 7, 2017, on February 2, 2017, the Company entered into a License Agreement with SolAero Technologies Corp. (“SolAero”), pursuant to which the Company agreed to grant SolAero a non-exclusive worldwide license to use, sell, offer for sale, import or otherwise dispose of certain products (the “Licensed Products”) using the Company’s patented proprietary manufacturing processes relating to Gallium Arsenide-based photovoltaic cells (the “Licensed Patents”) within the space and near-space fields of use (the “License Field”). SolAero is to pay the Company a royalty based on sales of the Licensed Products within the Licensed Field. The agreement does not provide SolAero with the right to sublicense the Licensed Patents. The term of the agreement runs from February 2, 2017 through the expiration date of the last expiring patent included in the Licensed Technology. However, each party may terminate the agreement upon a material breach by the other party.

 

There can be no assurance that our overall term operating plan will be successful or that we will be able to fulfill it, as it is largely dependent on raising capital and there can be no assurance that capital can be raised nor that we will be awarded the government contracts that we are currently pursuing in addition to the ARL Contract.

 

Results of Operations

 

For the three months ended March 31, 2018 and 2017

 

Revenue was $149,991 and $1,700 for the three months ended March 31, 2018 and 2017, respectively. The revenue for 2018 primarily relates to engineering services provided under the ARL contract.

 

We do not believe that inflation or changing prices have had a material effect on our business, financial condition, or results of operations.

 

Cost of Services

 

Cost of services was $149,991 and $38,002 for the three months ended March 31, 2018 and 2017, respectively. The increase was due to spending on the ARL contract during the quarter which was not in effect during the previous quarter.

 

Research and Development Expenses

 

Research and development expenses were $145,781 for the three months ended March 31, 2018, a 23% decrease from $189,161 for the three months ended March 31, 2017. The decrease is attributable to an overall reduction in expenses associated with our sponsored research activity including the suspension of our research agreement with the University of Michigan on August 30, 2017 as we increased our focus on product development and commercialization. The decrease was also due to a recapture of non-cash expenses consisting of warrants issued for services which were previously expensed resulting from fair value calculation. Non-cash expenses recaptured were $4,238 for the three months ended March 31, 2018 and non-cash expenses were $75,354 for the three months ended March 31, 2017. 

 

Patent Application and Prosecution Fees

 

Patent application and prosecution fees consist of the fees due for prosecuting and maintaining the patents resulting from the research program sponsored by the Company and were $327,157 for the three months ended March 31, 2018, a 10% decrease from $363,603 for the three months ended March 31, 2017. The year-over-year decrease is attributable to the timing of application and prosecution of patents and as a result of optimizing our patent portfolio.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses were $474,944 for the three months ended March 31, 2018, a 27% decrease from $650,781 for the three months ended March 31, 2017. The decrease is primarily attributable to a reduction in non-cash expenses associated with warrants issued to employees during the year. Non-cash expenses were $91,772 and $268,160 for the three months ended March 31, 2018 and 2017, respectively.

 

 16 

 

 

Other Income (Expense)

 

Other income (expense) for the three months ended March 31, 2018, was ($2,429,633) as compared to $3,818,623 for the three months ended March 31, 2017. These changes are primarily due to the gain (loss) on change in fair value of derivative liabilities, the timing of entering into interest bearing debt agreements and the timing of the conversion of existing debt and extinguishment of old debt.

  

Net Income (Loss)

 

The net income (loss) for the three months ended March 31, 2018 was ($3,377,515), compared to $2,578,776 for the three months ended March 31, 2017. The change in net income (loss) is impacted by non-cash expenses, including the gain on change in fair value of the derivative liability and loss on extinguishment of debt, offset by changes in research and development, patent application and prosecution fees, and selling, general and administrative expenses, each of which is described above.

 

Liquidity and Capital Resources

 

Sources of Liquidity

 

As of March 31, 2018, we had cash and cash equivalents of $12,497 and a working capital deficit of $10,734,649, as compared to cash and cash equivalents of $61,459 and a working capital deficit of $9,939,999 as of December 31, 2017. The decrease in working capital deficit is attributable to an increase in accrued liabilities and debt during the three months ended March 31, 2018.

 

The Company needs to raise additional capital and is in the process of raising additional funds in order to continue to finance our research and development, service existing liabilities and commercialize photonic energy conversion technologies utilizing organic and GaAs semiconductor-based solar cells. In the next 12 months we need to raise approximately $10 million in additional capital in order to continue our operations as described above and support our corporate functions. We anticipate that the additional funding can result from private sales of our equity securities. However, there can be no assurance that the additional funds will be available to us when needed, or if available, on terms that will be acceptable to us or our shareholders. If we are unable to raise sufficient funds, the Company may have to cease its operations.

 

Analysis of Cash Flows

 

Net cash used in operating activities decreased by $332,930 to $902,417 for the three months ended March 31, 2018, compared to $1,235,347 for the three months ended March 31, 2017. The cash used in operating activities was attributable primarily to the change in net income (loss), partially offset by the change in fair value of derivative liabilities and the loss on extinguishment of debt.

 

Net cash used in investing activities was $0 and $2,437 during the three months ended March 31, 2018 and 2017, respectively. This consisted of purchases of fixed assets.

 

Net cash provided by financing activities was $853,455 and $1,363,750 during the three months ended March 31, 2018 and 2017, respectively. For the three months ended March 31, 2018, this includes borrowings on related party debt of $300,000, borrowings on promissory note debt of $75,000, borrowing on convertible debt of $595,100, advances received from related party of $8,000, partially offset by repayments on convertible debt of $43,000 and advances repaid to related party of $81,465.  For the three months ended March 31, 2017, this includes proceeds from the sale of common shares and warrants of $50,000, subscription proceeds received for common shares and warrants to be issued of $193,750, borrowings on related party debt of $500,000, borrowings on convertible debt of 650,000, advances received from related party of $10,000, partially offset by advances repaid to related party of $40,000.

 

Going Concern

 

The Company has only generated limited revenues to date. The Company has a working capital deficit of $10,734,649 and an accumulated deficit of $219,922,635 as of March 31, 2018. The ability of the Company to continue as a going concern is dependent on raising capital to fund ongoing operations and carry out its business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

 

 17 

 

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements.

   

Critical Accounting Policies

 

There were no changes in our critical accounting policies during the three months ended March 31, 2018 from those set forth in “Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed with the SEC on March 27, 2018. 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Pursuant to Rule 13a-15(b) under the Exchange Act, the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Report. Based upon that evaluation, the Company’s management concluded that the Company’s disclosure controls and procedures were not effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.

 

Changes in internal controls over financial reporting

 

There have been no significant changes in our internal controls or in other factors that could significantly affect those controls subsequent to the period covered by this report. 

 

 18 

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

 

As reported in the Company’s prior filings, and specifically as described in the Company’s quarterly report for the quarter ended June 30, 2017, which was filed with the SEC on August 9, 2017, the Company was a party to a lawsuit in the United States District Court Southern District of New York, which was brought by John D. Kuhns. The parties have settled the matter. Pursuant to the settlement, all claims against the Company have been dismissed in exchange for issuing Mr. Kuhns 1,750,000 shares of the Company’s Common Stock and a promissory note for $125,000. This resulted in a loss on settlement of $633,292 recognized during 2017. The note is accruing interest at 12% per annum and due on May 31, 2018. The common stock was issued during the three months ended March 31, 2018.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Issuance of Promissory Notes and Warrants

 

During the three months ended March 31, 2018, the Company issued 250,000 warrants for the Company’s common shares with a strike price of $0.50 per share with promissory notes of $75,000. The relative fair value of the warrants of $33,736 was recognized as a debt discount which is being amortized on a straight-line basis over the term of the notes. The Company recognized interest expense of $7,203 associated with the amortization of debt discount on the notes and warrants issued during the current year for the three months ended March 31, 2018.

 

During the three months ended March 31, 2018, the Company issued an aggregate of 1,494,000 warrants with six convertible notes totaling $644,056. The relative fair value of the warrants was determined to be $288,919, which was recognized as a discount to the debt. This note also gave rise to a beneficial conversion feature of $63,742 which is recognized as additional paid in capital and a corresponding debt discount.

 

In March 2018, the Company borrowed $300,000 under a long-term note agreement with a major shareholder. The note accrues interest at 8% payable in stock the first two years and in cash or stock thereafter, at the shareholders choice, and has a 5-year term. Further, the major shareholder was issued a warrant to purchase 500,000 shares of the Company’s common stock with a 7-year term and an exercise price of $0.60. This note is convertible at $0.60 per share into common stock. The relative fair value of the 500,000 warrants was $108,300 which was recognized as a discount to the debt.

 

During the three months ended March 31, 2018, the Company issued an aggregate of 5,458,333 warrants to purchase the Company’s common stock in conjunction with debt modification agreements. The warrants have a 10-year term and exercise prices ranging from $0.50 to $1.00 per share. The fair value of the warrants was determined to be $1,741,512 using the Black-Scholes option pricing model which was recognized as loss on extinguishment of debt during the three months ended March 31, 2018.

 

The above issuances of the Company’s securities were not registered under the Securities Act of 1933, as amended (the “1933 Act”), and the Company relied on an exemption from registration pursuant to Section 4(2) of the 1933 Act, for such issuances.

 

Issuance of Common Stock and Warrants

 

On January 15, 2018, the Company issued 30,303 shares of its common stock to a consultant pursuant to a consulting agreement. The fair value of the common stock was determined to be $10,000 based on the stock price on January 15, 2018.

 

On February 12, 2018, the Company entered into a letter agreement with an investor pursuant to which the investor agreed to extend the maturity date of a promissory note which expired on February 12, 2018, to a new maturity date of May 14, 2018, and in exchange for agreeing to extend the maturity date of such note, the investor was issued 100,000 shares of the Company’s common stock and a warrant to purchase 2,000,000 shares of the Company’s common stock with a $0.50 per share exercise price and a 10 year term. The fair value of the warrants was determined to be $599,096 using the Black-Scholes option pricing model. The fair value of the common stock was determined to be $30,900 based on the stock price on February 12, 2018. These fair values were recorded as a total loss on extinguishment of debt of $629,996.

 

On February 23, 2018, the Company issued 1,750,000 shares of its common stock related to the settlement with John Kuhns. The fair value of the common stock was determined to be $681,625 based on the stock price on August 29, 2017 which was the original grant date.

 

On March 5, 2018, the Company issued 140,000 shares of the Company’s common stock to a related party pursuant to a letter agreement. The fair value of the common stock was determined to be $39,186 based on the stock price on March 5, 2018.

 

In March 2018, the Company issued 112,000 shares of the Company’s common stock to certain note holders in exchange for accrued interest of $56,000. The fair value of the common stock was determined to be $23,200 and resulted in a gain on settlement of accrued interest of $32,800.

 

 19 

 

 

The above issuances of the Company’s securities were not registered under 1933 Act, and the Company relied on an exemption from registration provided by Rule 506(b) of Regulation D promulgated under the 1933 Act for such issuances. 

 

The above issuances of the Company’s securities were not registered under the 1933 Act, and the Company relied on an exemption from registration pursuant to Section 4(2) of the 1933 Act for such issuances.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

Not applicable.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable. 

 

ITEM 5. OTHER INFORMATION

 

ITEM 6. EXHIBITS

  

    Incorporation by Reference
Exhibit No.  Description  Form  Exhibit  Filing Date
             
10.44   Securities Purchase Agreement with Power Up Lending Group dated January 16, 2018  8-K  10.1  01/25/2018
             
10.45   Convertible Promissory Note with Power Up Lending Group  8-K  10.2  01/25/2018
             
10.46   Securities Purchase Agreement with EMA Financial, LLC dated January 16, 2018  8-K  10.3  01/25/2018
             
10.47   Convertible Promissory Note for EMA Financial, LLC  8-K  10.4  01/25/2018
             
10.48   Securities Purchase Agreement with Crown Bridge, LLC dated January 23, 2018  8-K  10.1  02/05/2018
             
10.49   Convertible Promissory Note with Crown Bridge, LLC  8-K  10.2  02/05/2018
             
10.50   Crown Bridge Partners, LLC Warrant  8-K  10.3  02/05/2018

 

31.1

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

 
       
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*  
       
32.1   Certification of Principal Executive Officers and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*  
       
101.INS   XBRL Instance Document.  
       
101.SCH   XBRL Taxonomy Extension Schema Document.  
       
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document.  
       
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.  
       
101.LAB   XBRL Taxonomy Extension Label Linkbase Document.  
       
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document.  

 

* filed herewith

 

 20 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  NANOFLEX POWER CORPORATION
     
Date: May 15, 2018 By: /s/ Dean L. Ledger
    Dean L. Ledger
   

Chief Executive Officer

(principal executive officer)

     
Date: May 15, 2018 By: /s/ Ronald V. DaVella
    Ronald V. DaVella
   

Chief Financial Officer

(principal financial and accounting officer)

 

 

21